Lake Street analyst Frank Takkinen initiated coverage of Silk Road Medical with a Buy rating and $20 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on SILK:
- Silk Road Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- Silk Road Medical price target lowered to $9 from $12 at Stifel
- Silk Road Medical backs FY23 revenue view $170M-$174M, consensus $171.55M
- Silk Road Medical reports Q3 EPS (33c), consensus (35c)
- Silk Road Medical Reports Third Quarter 2023 Financial Results
